Profile | GDS4284 / 228412_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 59.9224 | 27 |
GSM687648 | Patient 402 control | 349.505 | 58 |
GSM687653 | Patient 403 control | 104.425 | 36 |
GSM687658 | Patient 404 control | 386.865 | 60 |
GSM687663 | Patient 411 control | 330.104 | 56 |
GSM687668 | Patient 422 control | 305.359 | 56 |
GSM687673 | Patient 424 control | 222.838 | 49 |
GSM687678 | Patient 425 control | 417.698 | 60 |
GSM687683 | Patient 427 control | 272.234 | 52 |
GSM687688 | Patient 428 control | 242.212 | 52 |
GSM687695 | Patient 441 control | 2097.43 | 86 |
GSM687699 | Patient 443 control | 436.037 | 60 |
GSM687704 | Patient 444 control | 164.082 | 44 |
GSM687707 | Patient 448 control | 119.12 | 33 |
GSM687712 | Patient 449 control | 77.6073 | 30 |
GSM687719 | Patient 450 control | 287.496 | 52 |
GSM687724 | Patient 451 control | 188.675 | 45 |
GSM687728 | Patient 452 control | 810.599 | 71 |
GSM687646 | Patient 401 treated 24h | 88.8043 | 32 |
GSM687649 | Patient 402 treated 24h | 221.333 | 51 |
GSM687665 | Patient 411 treated 24h | 404.119 | 59 |
GSM687651 | Patient 402 treated 4 weeks | 380.28 | 59 |
GSM687667 | Patient 411 treated 4 weeks | 215.079 | 49 |
GSM687670 | Patient 422 treated 24h | 286.372 | 54 |
GSM687671 | Patient 422 treated 4 weeks | 364.068 | 59 |
GSM687654 | Patient 403 treated 24h | 113.074 | 39 |
GSM687675 | Patient 424 treated 24h | 245.438 | 50 |
GSM687685 | Patient 427 treated 24h | 193.058 | 47 |
GSM687656 | Patient 403 treated 4 weeks | 103.255 | 38 |
GSM687677 | Patient 424 treated 4 weeks | 135.859 | 41 |
GSM687687 | Patient 427 treated 4 weeks | 197.598 | 49 |
GSM687692 | Patient 428 treated 4h | 204.871 | 49 |
GSM687716 | Patient 449 treated 4h | 178.975 | 47 |
GSM687722 | Patient 450 treated 4h | 298.585 | 53 |
GSM687680 | Patient 425 treated 24h | 262.531 | 53 |
GSM687690 | Patient 428 treated 24h | 273.154 | 55 |
GSM687700 | Patient 443 treated 24h | 744.803 | 68 |
GSM687705 | Patient 444 treated 24h | 151.615 | 44 |
GSM687714 | Patient 449 treated 24h | 154.139 | 45 |
GSM687721 | Patient 450 treated 24h | 561.071 | 64 |
GSM687682 | Patient 425 treated 4 weeks | 162.526 | 45 |
GSM687694 | Patient 428 treated 4 weeks | 212.997 | 51 |
GSM687702 | Patient 443 treated 4 weeks | 264.176 | 51 |
GSM687718 | Patient 449 treated 4 weeks | 207.942 | 49 |
GSM687723 | Patient 450 treated 4 weeks | 97.7313 | 33 |
GSM687661 | Patient 404 treated 4h | 491.632 | 63 |
GSM687710 | Patient 448 treated 4h | 145.236 | 42 |
GSM687726 | Patient 451 treated 4h | 186.857 | 44 |
GSM687730 | Patient 452 treated 4h | 1246.02 | 78 |
GSM687660 | Patient 404 treated 24h | 1682.9 | 83 |
GSM687697 | Patient 441 treated 24h | 1963.48 | 84 |
GSM687709 | Patient 448 treated 24h | 451.786 | 62 |
GSM687725 | Patient 451 treated 24h | 107.383 | 31 |
GSM687729 | Patient 452 treated 24h | 1574.82 | 82 |
GSM687727 | Patient 451 treated 4 weeks | 150.841 | 39 |
GSM687731 | Patient 452 treated 4 weeks | 694.767 | 68 |